Select Medical

SEM

Market cap $1.88B

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Select Medical draws investor focus as its executive chairman offers a take-private idea at up to a 15.6% premium to the latest close.

MECHANICSBURG, Pa. , Nov. 24, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) has received a non-binding indication of interest from Robert A.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

SEM's Q3 earnings drop 11.5% year over year due to the rising cost of services, despite a revenue beat and raised 2025 EPS guidance.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Select Medical (SEM) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

The consensus price target hints at a 35.9% upside potential for Select Medical (SEM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Select Medical Holdings Corporation ( SEM ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Robert Ortenzio - Co-Founder & Executive Chairman Thomas Mullin - Chief Executive Officer Michael Malatesta - Executive VP & CFO Conference Call Participants Benjamin Hendrix - RBC Capital Markets, Research Division Justin Bowers - Deutsche Bank AG, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Albert Rice - UBS Investment Bank, Research Division Presentation Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the third quarter 2025 results and the company's business outlook. Presenting today are the company's Executive Chairman and Co-Founder, Robert Ortenzio; the company's Chief Executive Officer, Thomas Mullin; and the company's Executive Vice President and Chief Financial Officer, Michael Malatesta.